Philips CPAP Cancer Lawsuit News

Results of Phillips-Funded Studies Call The Use of Ozone Cleaning Products Into Question

Studies of recalled CPAP machines have found that foam degradation is 14 times more likely when using Ozone cleaning products

Wednesday, July 20, 2022 - Phillips Respironics, makers of the recalled Philips line of CPAP sleep apnea machines, has commissioned five independent testing laboratories with the task of finding whether or not the devices' sound abatement foam is made from substandard materials and degrades into particles, chemicals, and gasses. Thousands of Phillips CPAP lawsuits against the company have alleged that the Phillips DreamStation CPAP sleep apnea machine's sound cancellation foam degrades and causes carcinogenic material to be released into the device's airway to be inhaled repeatedly throughout the night with every breath. In late June 2022, the company issued the results of several tests. Phillips has never admitted that sound abatement foam was faulty and complied with the recall order in the United States "out of an abundance of caution", and with concern for the health of their customers. Lawsuits have accused the company of knowing about the sound abatement foam problem years ago based on email complaints made by customers to the company. Phillips stands accused of covering up the fact that there were complaints about dirty airways to them.

Royal Phillips CEO Frans van Houten told the media that the tests on the machines in question have been completed and have yielded encouraging results. He also reiterated his accusations that the sound abatement foam degradation was due to using an unapproved Ozone cleaning solution. " results to date for the first-generation DreamStation devices, which represent the majority of the registered affected devices, show a very low prevalence of visible foam degradation. In addition, the new and used first-generation DreamStation devices passed volatile organic compound and respirable particulate emission testing. This is very encouraging. Results to date also indicate that ozone cleaning significantly exacerbates foam degradation," as written on Phillips.com. For the record, the US Food and Drug Administration (FDA) has not approved Ozone cleaning products, solutions, or methods for sale, thinking that they may cause problems with the underlying devices they are intended to sterilize. Also of interest is that none of the more than 2000 recalled devices from the EU or Japan showed any visible foam degradation. The study also found that upon visual inspection, particulate matter found inside the device's airways may have been caused by the user failing to clean the device and not by sound abatement foam. "average particulate matter counts in devices classified as 'dirty' were significantly greater than those classified as 'clean," Phillips writes.

All this is in response to customers that have suffered a variety of series lung and breathing-related health problems including but not limited to developing lung cancer allegedly from breathing the toxins in their CPAP device's airway. Phillips CPAP cancer lawyers continue to interview former users of the DreamStation and other CPAP sleep apnea devices manufactured by the company. Royal Phillips is also being sued by SoClean Inc., the manufacturer of the majority of the controversial ozone cleaning products Phillips CPAP customers allegedly used to clean their devices.

More Recent Philips CPAP Cancer Lawsuit News:

Lawyers for CPAP Cancer Lawsuits

We will represent all persons in involved in a BiPAP or CPAP cancer lawsuit on a contingency basis, meaning there are never any legal fees unless we win compensation in your case. Anyone who developed cancer or another serious side effect as a result of using a Philips CPAP sleep apnea machine or ventilator in --or is a family member of such a person--is eligible to receive a free, no-obligation case review from our attorneys. Simply contact our firm through the online contact form or the chat feature and one of our Philips BiPAP cancer lawyers serving will contact you promptly to discuss your case.



Privacy Notice: This site uses cookies for advertising, analytics and to improve our site services. By continuing to use our site, you agree to our use of cookies. For more information, see our cookie and privacy policy.